Pembrolizumab-Associated Optic Neuritis With an Unusual Manifestation of Monocular Optic Disc Edema
- PMID: 36728538
- DOI: 10.1097/WNO.0000000000001798
Pembrolizumab-Associated Optic Neuritis With an Unusual Manifestation of Monocular Optic Disc Edema
Conflict of interest statement
The authors report no conflicts of interest.
References
-
- Liu GT, Volpe NJ, Galetta SL. Liu, Volpe, and Galetta's Neuro-Ophthalmology: Diagnosis and Management. 3rd edition. Philadelphia: Elsevier, 2019.
-
- Nassar A, Rivera N, Mora J, Martinez A. A bilateral optic neuritis side effect of biological treatment with pembrolizumab in a patient with metastatic melanoma. J Neurol Stroke. 2020;10:177–181.
-
- Francis JH, Jaben K, Santomasso BD, Canestraro J, Abramson DH, Chapman PB, Berkenstock M, Aronow ME. Immune checkpoint inhibitor-associated optic neuritis. Ophthalmology. 2020;127:1585–1589.
-
- Dalvin LA, Shields CL, Orloff M, Sato T, Shields JA. Checkpoint inhibitor immune therapy: systemic indications and ophthalmic side effects. Retina. 2018;38:1063–1078.
-
- Yu CW, Yau M, Mezey N, Joarder I, Micieli JA. Neuro-ophthalmic complications of immune checkpoint inhibitors: a systematic review. Eye Brain. 2020;12:139–167.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
